Schedule 13D ownership disclosure

Onconetix, Inc.

Common Stock, $0.00001 par value per share · CUSIP: 68237Q104

Event date: 2025-01-02

Filing-level shares
673,365.00
Percent of class
4.63%
  • Ralph SchiessReported CIK 0002006201

    Shares: 673,365.00 · Class: 4.63%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-25-014283
Form type
SCHEDULE 13D/A
Filer
Onconetix, Inc.
CIK
CIK 1782107
Filed
Feb 14, 2025
Reporting period
Jan 02, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub